Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets
dc.contributor.author | Cooling, Laura L. | en_US |
dc.contributor.author | Downs, Theresa A. | en_US |
dc.contributor.author | Butch, Suzanne H. | en_US |
dc.contributor.author | Davenport, Robertson D. | en_US |
dc.date.accessioned | 2010-06-01T20:25:53Z | |
dc.date.available | 2010-06-01T20:25:53Z | |
dc.date.issued | 2008-10 | en_US |
dc.identifier.citation | Cooling, Laura L.; Downs, Theresa A.; Butch, Suzanne H.; Davenport, Robertson D. (2008). "Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets." Transfusion 48(10): 2106-2113. <http://hdl.handle.net/2027.42/73545> | en_US |
dc.identifier.issn | 0041-1132 | en_US |
dc.identifier.issn | 1537-2995 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73545 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18631162&dopt=citation | en_US |
dc.description.abstract | Although uncommon, acute hemolytic transfusion reactions (AHTRs) have been reported after transfusion of group O single-donor apheresis platelets (SDPs) to group A, B, and AB recipients. Current methods for identifying “high-titer” SDPs include tube and gel methods. The risk of a high-titer unit is considered low with group O, poststorage, pooled platelet concentrates (PPLTs); however, data regarding anti-A and anti-B titers in PPLTs are lacking. STUDY DESIGN AND METHODS: Anti-A and anti-B titers were determined in 185 PPLTs by direct agglutination using manual gel and tube methods. PPLTs tested included 124 group O PPLTs, 25 group A PPLTs, 26 group B PPLTs, and 10 PPLTs containing a mix of either groups O plus A or groups O plus B (mixed PPLTs). The reciprocal of the highest dilution giving macroscopic agglutination was considered the agglutinin titer. RESULTS: Mean anti-A and anti-B titers in group O PPLTs were, respectively, 16 and 8 by tube and 64 and 32 by gel (p < 0.0001). Gel titers were one to two dilutions higher than tube and sensitive to reagent red cell lots. With the use of at least 64 as a critical titer, 60 percent of group O PPLTs tested by gel would be considered high-titer. In mixed PPLTs, the addition of one non-group O PLT significantly decreased or neutralized the corresponding anti-A or anti-B (p < 0.0001). CONCLUSION: Anti-A and anti-B titers in group O PPLTs are comparable to those reported in group O SDPs and significantly lower than titers reported in AHTR. A critical direct agglutinin titer of 64 for identifying high-titer units by gel is too low and should be increased to 128 or higher. | en_US |
dc.format.extent | 331091 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Inc | en_US |
dc.rights | © 2008 AABB | en_US |
dc.title | Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 18631162 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73545/1/j.1537-2995.2008.01814.x.pdf | |
dc.identifier.doi | 10.1111/j.1537-2995.2008.01814.x | en_US |
dc.identifier.source | Transfusion | en_US |
dc.identifier.citedreference | Cooling L. ABO and platelet transfusion therapy. Immunohematology 2007; 23: 20 - 33. | en_US |
dc.identifier.citedreference | Fung MK, Downes KA, Shulman IA. Transfusion of platelets containing ABO-incompatible plasma. Arch Pathol Lab Med 2007; 131: 909 - 16. | en_US |
dc.identifier.citedreference | Harris SB, Josephson CD, Kost CB, Hillyer CD. Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A. Transfusion 2007; 47: 1412 - 7. | en_US |
dc.identifier.citedreference | Schwartz J, Depalma H, Kapoor K, Hamilton T, Grima K. Anti-A titers in group O single donor platelets: to titer or not to titer [abstract ]. Transfusion 2003; 43 Suppl: SP247. | en_US |
dc.identifier.citedreference | Fauzie D, Shirey RS, Thoman S, Bensen-Kennedy D, King KE. The risk of hemolytic transfusion reactions due to passively-acquired ABO antibodies: a retrospective study of non-group O adult recipients of group O plateletpheresis transfusions [abstract ]. Transfusion 2004; 44 Suppl: SP10. | en_US |
dc.identifier.citedreference | Mair B, Benson K. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets. Transfusion 1998; 38: 51 - 5. | en_US |
dc.identifier.citedreference | Larsson LG, Welsh VJ, Ladd DJ. Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 2000; 40: 902 - 6. | en_US |
dc.identifier.citedreference | Pietersz RN, Engelfriet CP, Reesink HW. International forum: transfusion of apheresis platelets and ABO groups. Vox Sang 2005; 88: 207 - 21. | en_US |
dc.identifier.citedreference | Josephson CD, Mullis NC, Van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelets have “high titer” anti-A/A,B: implications for transfusion policy. Transfusion 2004; 44: 805 - 8. | en_US |
dc.identifier.citedreference | Brecher M. Technical manual. 15th ed. Bethesda (MD): American Association of Blood Banks; 2005. | en_US |
dc.identifier.citedreference | 11. Buffered MTS gel card (direction circular). Pompano Beach (FL): Micro Typing Systems; 1994. | en_US |
dc.identifier.citedreference | Friedberg RC, Donnelly SF, Boyd JC, Gray LS, Mintz PD. Clinical and blood bank factors in the management of platelet refractoriness. Blood 1993; 81: 3428 - 34. | en_US |
dc.identifier.citedreference | Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, Kickler T, Lee E, McFarland J, McCullough J, Rodey G, Schiffer CA, Woodson RW. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005; 105: 4106 - 14. | en_US |
dc.identifier.citedreference | Cooling LL, Kelly K, Barton J, Hwang D, Koerner TA, Olson JD. Determinants of ABH expression on human blood platelets. Blood 2005; 105: 3356 - 64. | en_US |
dc.identifier.citedreference | Jimenez TM, Patel SB, Pineda AA, Tefferi A, Owen WG. Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility. Transfusion 2003; 43: 328 - 34. | en_US |
dc.identifier.citedreference | Heal JM, Blumberg N, Masel D. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood 1987; 70: 23 - 30. | en_US |
dc.identifier.citedreference | Brand A, Sintnicolaas K, Claas FH, Eernisse JG. ABH antibodies causing platelet transfusion refractoriness. Transfusion 1986; 26: 463 - 6. | en_US |
dc.identifier.citedreference | Langston MM, Procter JL, Cipolone KM, Stroncek DF. Evaluation of the gel system for ABO grouping and D typing. Transfusion 1999; 39: 300 - 5. | en_US |
dc.identifier.citedreference | Kettler DS, Johnson MM. ABO grouping: experience with the gel test [abstract]. Transfusion 1997; 37 Suppl: 29S. | en_US |
dc.identifier.citedreference | Mazda T, Yabe R, NaThalang O, Thammavong T, Tadokoro K. Differences in ABO antibody among blood donors: a comparison between past and present Japanese, Laotian, and Thai populations. Immunohematology 2007; 23: 38 - 41. | en_US |
dc.identifier.citedreference | Saphire DG, Rudolph NS, Hackleman SM, Stone WH. The effect of age on the level of human ABO blood group antibodies. Aging Clin Exp Res 1993; 5: 177 - 84. | en_US |
dc.identifier.citedreference | Aubert EF, Boorman KE, Dodd BE, Loutit JF. The universal donor with high titre iso-agglutinins: the effect of anti-A iso-agglutinins on recipients of group A. BMJ 1942; 1: 659 - 64. | en_US |
dc.identifier.citedreference | Tisdall LH, Garland DM, Szanto PB, Hand AM, Bonnett JC. The effects of high isoagglutinin titer into recipients of other blood groups. Am J Clin Pathol 1946; 16: 193 - 206. | en_US |
dc.identifier.citedreference | Ebert RV, Emerson CP. A clinical study of transfusion reactions: the hemolytic effect of group-O blood and pooled plasma containing incompatible isoagglutinins. J Clin Invest 1946 25: 627 - 38. | en_US |
dc.identifier.citedreference | Thalhimer W, Taylor ES. The low agglutinin titer of both small and large pools of plasma. JAMA 1945; 128: 277 - 9. | en_US |
dc.identifier.citedreference | Beading W, Cooling LW. Immunohematology. In: McPherson RA, Pinkus MR, editors. Henry's clinical diagnosis and management by laboratory methods. 21st ed. Philadelphia (PA): WB Saunders; 2007. p. 619 - 69. | en_US |
dc.identifier.citedreference | Klendshoj NC, Witebsky E. Transfusion of O blood conditioned by the addition of blood group specific substances. JAMA 1945; 129: 1091 - 3. | en_US |
dc.identifier.citedreference | Miller EB, Tisdall LH. Reactions to 10,000 pooled liquid human plasma transfusions. JAMA 1945; 128: 863 - 7. | en_US |
dc.identifier.citedreference | Solheim BG. Universal pathogen-reduced plasma in elective open-heart surgery and liver resection. Clin Med Res 2006; 4: 209 - 17. | en_US |
dc.identifier.citedreference | Chapanduka ZC, Fernandes-Costa FJ, Rochat C, Blyth DF. Comparative safety and efficacy of Bioplasma FDP versus single-donor fresh-dried plasma in cardiopulmonary bypass patients. S Afr Med J 2002; 92: 356 - 7. | en_US |
dc.identifier.citedreference | Rochat C, Larkin PM. Determination of proportion of ABO blood groups in manufacture of Bioplasma FDP: a universal plasma? [abstract]. Vox Sang 2006; 91 Suppl 3: P474. | en_US |
dc.identifier.citedreference | Heal JM, Masel D, Blumberg N. Interaction of platelet Fc and complement receptors with circulating immune complexes involving the ABO system. Vox Sang 1996; 71: 205 - 11. | en_US |
dc.identifier.citedreference | Heal JM, Masel D, Rowe JM, Blumberg N. Circulating immune complexes involving the ABO system after platelet transfusion. Br J Haematol 1993; 85: 566 - 72. | en_US |
dc.identifier.citedreference | Huang MM, Indik Z, Brass LF, Hoxie JA, Schreiber AD, Brugge JS. Activation of FcγRII induces tyrosine phosphorylation of multiple proteins including FcγRII. J Biol Chem 1992; 267: 5467 - 73. | en_US |
dc.identifier.citedreference | Sweeney J, Kouttab N, Holme ST, Cheves T, Nelson E. In vitro evaluation of prestorage pools consisting of mixed A and O platelet concentrates. Transfusion 2007; 47: 1154 - 61. | en_US |
dc.identifier.citedreference | 36. Policies on combining ABO non-identical platelet concentrates in the same pool. CBBS, e-network forum. Sacramento, CA: CBBS Central Office; 2004 Aug 22 [cited 2007 Feb 23]. Available from: http://www.cbbsweb.org/enf/2004/pltpool_mixabo.html. | en_US |
dc.identifier.citedreference | Sadani DT, Urbaniak SJ, Bruce M, Tighes JE. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. Transfus Med 2006; 16: 375 - 9. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.